{"schema_version":"secwatch.filing_event.v1","accession":"0000313616-26-000201","form_type":"8-K","ticker":"DHR","cik":"0000313616","company_name":"DANAHER CORP /DE/","filed_at":"2026-10-20T21:43:14+00:00","discovered_at":"2026-10-21T10:05:00.308947+00:00","generated_at":"2026-10-21T10:05:55.574234+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.76,"calibrated_materiality_score":0.76,"confidence":"high","headline":"Danaher Q3 2026 EPS $1.71, adjusted $2.11; revenue $6.6B up 8.5%, FY EPS guidance raised","bullets":["Net earnings $1.2B, or $1.71 per diluted share, up 34.5% YoY; non-GAAP adjusted diluted EPS $2.11, up 11.5%.","Revenue $6.6B, up 8.5% YoY; core revenue rose 3.0% and core excluding respiratory rose 5.5%.","Operating cash flow $1.9B; non-GAAP free cash flow $1.6B.","Q4 2026 outlook: core revenue excluding respiratory up 4.0%-5.0%; respiratory a ~150 bps headwind, core revenue up ~3.0%.","FY 2026 adjusted diluted EPS guidance raised to $8.57-$8.62 from $8.45-$8.60."],"urls":{"canonical":"https://secwatch.observer/filing/0000313616-26-000201","json":"https://secwatch.observer/filing/0000313616-26-000201.json","markdown":"https://secwatch.observer/filing/0000313616-26-000201.md","text":"https://secwatch.observer/filing/0000313616-26-000201.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000201/0000313616-26-000201-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000201/dhr-20261021.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-21T10:05:55.574234+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}